Virtual Meeting October 2-3, 2020
Quanterix will be sponsoring this meeting with a presentation followed with Q&A by Paula Perin, PhD - Senior Field Applications Scientist
Paula will be discussing the unique ultra-sensitive, multiplexing capability of Simoa Planar technology and its applications in the field of oncology and immuno-oncology.
Date/Time: October 2, 2020 12.30 – 13.00 CEST (Central European Summer Time)
The 7th Immunotherapy of Cancer Conference (ITOC7) to be held virtually from October 2 - 3, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.